| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.003 | 1 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.0031 | 1 |